RENVELA
RENVELA
Discontinued
DIN Number
02485559
Drug Class
Human
Market Date
Oct 25, 2019
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02485559
AIG Number0152763002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AE02 SEVELAMER
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationOral
AHFS Classification40:18.19
Health Canada Classification
ACTIVE INGREDIENTS (1)
SEVELAMER CARBONATEActive
Strength: 0.8 G / SACHET
Monograph: SEVELAMER CARBONATE